BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28178363)

  • 1. Ranolazine for stable angina pectoris.
    Salazar CA; Basilio Flores JE; Veramendi Espinoza LE; Mejia Dolores JW; Rey Rodriguez DE; Loza Munárriz C
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011747. PubMed ID: 28178363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers in patients without heart failure after myocardial infarction.
    Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
    Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib for rheumatoid arthritis.
    Fidahic M; Jelicic Kadic A; Radic M; Puljak L
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012095. PubMed ID: 28597983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-based cardiac rehabilitation for adults with stable angina.
    Long L; Anderson L; Dewhirst AM; He J; Bridges C; Gandhi M; Taylor RS
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012786. PubMed ID: 29394453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient education in the management of coronary heart disease.
    Anderson L; Brown JP; Clark AM; Dalal H; Rossau HK; Bridges C; Taylor RS
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD008895. PubMed ID: 28658719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrates for primary prevention of cardiovascular disease events.
    Jakob T; Nordmann AJ; Schandelmaier S; Ferreira-González I; Briel M
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009753. PubMed ID: 27849333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis.
    Al Said S; Kaier K; Sumaya W; Alsaid D; Duerschmied D; Storey RF; Gibson CM; Westermann D; Alabed S
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD014678. PubMed ID: 38264795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD001511. PubMed ID: 29096421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman O; Elsayed Z
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD010693. PubMed ID: 29197071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.